ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting

Atherosclerosis

Volumn 218, Issue 2, 2011, Pages 457-463

  Regieli, Jakub J ^a   Doevendans, Pieter A ^a   Grobbee, Diederick E ^a   Zwinderman, Aeilko H ^b   Van Der Graaf, Yolanda ^a   Kastelein, John J P ^b   Jukema, J Wouter ^c,d,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d Durrer Center for Cardiogenetic Research   (Netherlands)

^e Established Investigator of the Netherlands   (Netherlands)

Author keywords

Coronary disease; Epidemiology; Lipoproteins; Prevention; Survival

Indexed keywords

ABC TRANSPORTER A1;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SECONDARY PREVENTION; SURVIVAL RATE; THROMBOSIS;

AGED; ALLELES; ANGIOGRAPHY; ATP-BINDING CASSETTE TRANSPORTERS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK; THROMBOSIS; TREATMENT OUTCOME;

EID: 81155160905     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.008     Document Type: Article

References (29)

1. Frikke-Schmidt R., Nordestgaard B.G., Schnohr P., Steffensen R., Tybjaerg-Hansen A. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population. J Am Coll Cardiol 2005, 46:1516-1520.
2. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Steffensen R., Tybjaerg-Hansen A. Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 2008, 28:180-186.
3. Frikke-Schmidt R., Nordestgaard B.G., Stene M.C., et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008, 299:2524-2532.
4. Joyce C.W., Amar M.J., Lambert G., et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 2002, 99:407-412.
5. Orso E., Broccardo C., Kaminski W.E., et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 2000, 24:192-196.
6. Assmann G., von Eckardstein A., Bryan Brewer H. Familial Analphalipoproteinemia: Tangier Disease. The metabolic & molecular bases of inherited disease 2001, 2937-2960.
7. Ferrans V.J., Fredrickson D.S. The pathology of Tangier disease. A light and electron microscopic study. Am J Pathol 1975, 78:101-158.
8. Nofer J.R., Herminghaus G., Brodde M., et al. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004, 279:34032-34037.
9. Zwarts K.Y., Clee S.M., Zwinderman A.H., et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 2002, 61:115-125.
10. Schmitz G., Buechler C. ABCA1: regulation, trafficking and association with heteromeric proteins. Ann Med 2002, 34:334-347.
11. Porsch-Ozcurumez M., Langmann T., Heimerl S., et al. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J Biol Chem 2001, 276:12427-12433.
12. Santamarina-Fojo S., Peterson K., Knapper C., et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA 2000, 97:7987-7992.
13. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000, 275:28240-28245.
14. Langmann T., Porsch-Ozcurumez M., Heimerl S., et al. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 2002, 277:14443-14450.
15. Kyriakou T., Hodgkinson C., Pontefract D.E., et al. Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:418-423.
16. Jukema J.W., Bruschke A.V., van Boven A.J., et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995, 91:2528-2540.
17. Kuivenhoven J.A., Jukema J.W., Zwinderman A.H., et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998, 338:86-93.
18. Herings R.M., Bakker A., Stricker B.H., Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Commun Health 1992, 136-140.
19. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto A.M., Marian A.J. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 2001, 88:969-973.
20. Tregouet D.A., Ricard S., Nicaud V., et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 2004, 24:775-781.
21. Tregouet D.A., Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007, 23:1038-1039.
22. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
23. Jensen M.K., Pai J.K., Mukamal K.J., Overvad K., Rimm E.B. Common genetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk of coronary heart disease. Atherosclerosis 2007, 195:e172-e180.
24. Martin M., Gonzalez P., Reguero J.J., et al. ABCA1 polymorphisms and prognosis after myocardial infarction in young patients. Int J Cardiol 2006, 110:267-268.
25. Schmitz G., Heimerl S., Langmann T. Zinc finger protein ZNF202 structure and function in transcriptional control of HDL metabolism. Curr Opin Lipidol 2004, 15:199-208.
26. Wagner S., Hess M.A., Ormonde-Hanson P., et al. A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem 2000, 275:15685-15690.
27. Stene M.C., Frikke-Schmidt R., Nordestgaard B.G., Grande P., Schnohr P., Tybjaerg-Hansen A. Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease. J Am Coll Cardiol 2008, 52:369-377.
28. Langmann T., Schumacher C., Morham S.G., et al. ZNF202 is inversely regulated with its target genes ABCA1 and apoE during macrophage differentiation and foam cell formation. J Lipid Res 2003, 44:968-977.
29. Assmann G., von Eckardstein A., Bryan Brewer H. Familial analfalipoproteinemia: Tangier disease. The metabolic & molecular bases of inherited disease 2001, 2937-2960. OH McGraw-Hill Inc, Columbus. C.R. Scriver, B. Childs (Eds.).